Cellerant Therapeutics Inc.

Cellerant is a clinical-stage biotechnology company developing a portfolio of adult stem cell-derived products that could potentially regulate the hematopoietic (blood forming) system. It currently has two products in clinical development: a highly purified hematopoietic stem cell product that is a curative therapy for sickle cell disease, autoimmune diseases and cancers, and a manufactured cell product for the treatment of neutropenia in patients at risk for infection following stem cell transplant or chemotherapy.